Trial intelligence / Profile preview

Rosuvastatin for Microvascular Resistance in Women with Chest Pain

NCT01582165Phase 4Completed

Sponsor
Oslo University Hospital
Start
Jun 2012
Primary completion
Jun 2016
Modality
Orthosteric Ligands
Countries
1
01

Overview

A Phase 4 trial of rosuvastatin in angina pectoris, sponsored by Oslo University Hospital. Started Jun 2012; status: completed.

02

Drugs

rosuvastatin
03

Conditions

angina pectoris

Beyond the preview

Go deeper on NCT01582165.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01582165.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call